| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
SPECIAL SECTION |
Correspondence: For more information, or for patient referral, contact Dr. Charles Hesdorffer at telephone: 212-305-4907, or e-mail: hesdorffer{at}cuccfa.ccc.columbia.edu or Dr. David Savage at telephone: 212-305-9783, or e-mail: savage{at}cuccfa.ccc.columbia.edu
The Patient Care section of The Oncologist extends the opportunity for major cancer centers to enroll patients in high-priority clinical trials. If you wish to have your clinical trial(s) announced, send all pertinent details to the Executive Editor.
| Dispatches from: |
|---|
|
|
|---|
Poor-risk Hodgkins and non-Hodgkins lymphoma, including patients with high-risk features at diagnosis (e.g., bulky disease, adverse histology), chemoresistant disease, and relapse.
Small cell and non-small cell lung cancer, either at diagnosis prior to treatment or in patients with chemoresponsive disease.
Brain tumors, including patients with newly diagnosed glioblastoma, as well as recurrent anaplastic astrocytomas and oligodendrogliomas.
Breast cancer, including patients with metastatic disease.
Multiple myeloma.
Ovarian cancer.
MDR gene therapy for patients with stage 4 breast cancer, brain tumors and ovarian cancer entering other institutional high-dose protocols.
CD34 cell selection and purging for patients with myeloma and lymphoma.
Immunotherapy for patients with breast cancer post-transplantation.
THE HOUSTON POST
New therapies available at M.D. Anderson Cancer Center now can be found on the World Wide Web.
Cancer patients wanting cutting-edge therapy or whose disease no longer responds to traditional treatment may find new hope on the "information superhighway."
The University of Texas M.D. Anderson Cancer Center has posted its clinical trials available for cancer patients on a World Wide Web site at: www.clinicaltrials.org. The information, and a variety of additional information, also may be located through M.D. Andersons home page on the World Wide Web at www.mdanderson.org.
"Clinical research studies offer patients cancer treatments they otherwise could not receive and usually result in improved therapies," says Dr. Leonard Zwelling, Associate Vice President for Clinical and Translational Research. Dr. Zwelling explained that in cancer research, a clinical trial generally refers to evaluating new treatment methods such as surgery, drugs or radiation techniques, although methods of prevention, detection or diagnosis also may be the subject of such studies.
Currently, more than 200 clinical trials open for enrollment are posted for easy access to patients. Treatments available can be viewed by cancer type (for example, breast cancer or prostate cancer), by name of the physician conducting the study, or by the treatment agent(s) being used in the study.
The URL is: www.clinicaltrials.org
| FOOTNOTES |
|---|
|
|
|---|
Look for our expanded coverage on clinical trials in future Patient Care sections of The Oncologist.
| ||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |